A Japanese study reported that anterior segment OCT imaging can predict one-year success following PreserFlo MicroShunt surgery. By linking imaging features to surgical outcomes, the work aims to help clinicians identify likely responders earlier and refine post-operative planning. The results were published in Advances in Therapy and focus on the real-world variability in minimally invasive glaucoma surgery, where the same procedure can yield different outcomes across patients. An OCT-based approach could support more individualized decision-making for patient selection and monitoring intensity, potentially reducing time to detect inadequate intraocular pressure control. For glaucoma programs and device makers, it adds to the evidence base for imaging biomarkers that may improve surgical risk stratification over time.